Therefore, our results suggest that despite overexpression of EGFR, PDGFRA, CDK4, and/or MDM4 is a hallmark of GBM, increased expression of these genes is not fully explained by underlying genetic amplification and/or mutations/deletions, other mechanisms potentially leading also to activation of these genes in GBM. This evidence concerns the gene EGFR and glioblastoma.